Patrick Cauntay

Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts

Sebastien A. Burel, Christopher E. Hart, Patrick Cauntay et al. · Nucleic Acids Research · 2015 · 191 citations · Full text

Immunology, Molecular Biology, Long Pre-mrna Transcripts +17

Comprehensive Structure–Activity Relationship of Triantennary<i>N</i>-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to Hepatocytes

Thazha P. Prakash, Jinghua Yu, Michael T. Migawa et al. · Journal of Medicinal Chemistry · 2016 · 131 citations

Unique O-Methoxyethyl Ribose-DNA Chimeric Oligonucleotide Induces an Atypical Melanoma Differentiation-Associated Gene 5-Dependent Induction of Type I Interferon Response

Sebastien A. Burel, Todd Machemer, Frank L. Ragone et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 30 citations

The Distinct and Cooperative Roles of Toll-Like Receptor 9 and Receptor for Advanced Glycation End Products in Modulating <i>In Vivo</i> Inflammatory Responses to Select CpG and Non-CpG Oligonucleotides

Suzanne Paz, Jill Hsiao, Patrick Cauntay et al. · Nucleic Acid Therapeutics · 2017 · 28 citations

Inflammatory Non-CpG Antisense Oligonucleotides Are Signaling Through TLR9 in Human Burkitt Lymphoma B Bjab Cells

Adam J. Pollak, Patrick Cauntay, Todd Machemer et al. · Nucleic Acid Therapeutics · 2022 · 16 citations